ANRASXAnatara Lifesciences Ltd

ANR price activity

Last Price

Change (24hr)

AUD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

ANR price performance

-10%

-35,71%

YTD

12,5%

ANR price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

AU-ASX rank

N/A

Sector Rank

N/A

ANR details

View company website

View AU-ASX Official Page

Dividendos de ANR

Ver mais

quote.marketSignals

Mais formas de descobrir

Ver notícias de Australia Descubra sinais de ASX Ver todas as ações de ASX Ver todos os ETFs de ASX

Anatara Lifesciences Ltd (AU-ASX: ANR)

Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in Australia. The company's products include Gastrointestinal ReProgramming, a multi-component, multi-coated medicine designed to address underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease; and Detach for the treatment of diarrhea in piglets. It also develops anti-obesity project, an oral medication to assist weight reduction and control. Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia.

Price: A$0.01

Sector: Healthcare — Biotechnology